FDA shatters generic drug approval record

pills
The Food and Drug Administration had another record-setting amount of generic drug approvals for federal fiscal 2018. (Pixabay)

The Food and Drug Administration has approved or tentatively approved 1,028 generic drugs since the end of July, ensuring another record federal fiscal year of approvals.

The agency’s total already surpasses the 971 approvals for the 2018 federal fiscal year, which runs from Sept. 30 to Oct. 1.

“A robust generics drug program isn’t just about how many applications we approve in a given month or year,” said FDA acting Commissioner Ned Sharpless in a tweet Friday. “We continue to efficiently and successfully work with industry to improve the quality of their applications.”

Case Study

Across-the-Board Impact of an OB-GYN Hospitalist Program

A Denver facility saw across-the-board improvements in patient satisfaction, maternal quality metrics, decreased subsidy and increased service volume, thanks to the rollout of the first OB-GYN hospitalist program in the state.

Sharpless said the agency has focused on decreasing the number of review cycles for applications and working with companies earlier in the review process to ensure applications are prepared correctly.

RELATED: Latest generic drug deal puts hospital-owned Civica Rx ahead of schedule

The agency has increased resources for generic drug approvals since the passage of a generic drug user fee program back in 2012. The Trump administration’s drug pricing blueprint also called for more drug price approvals.

However, while generic drug approvals have increased, research shows that the highest driver of prescription drug costs is specialty drugs for chronic conditions such as cancer.

A recent drug pricing forecast from Vizient’s pharmacy program found that health systems can expect a nearly 5% hike in the cost of drug purchases next year. The report found that inflation is going to be more than 4% in the specialty drug market.

Suggested Articles

Aetna is partnering with Emory Healthcare and Northside Hospital System to bring its Whole Health program to the Atlanta market. 

CMS wants to make it easier for docs to report progress on MIPS via their electronic health records so they "don't have to lift a finger."

A court ruling upheld a rule restricting what clinicians in federally-funded family planning clinics can tell patients about abortion.